Eftihia Cocolakis

1.5k total citations
20 papers, 1.2k citations indexed

About

Eftihia Cocolakis is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Eftihia Cocolakis has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Genetics. Recurrent topics in Eftihia Cocolakis's work include TGF-β signaling in diseases (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Eftihia Cocolakis is often cited by papers focused on TGF-β signaling in diseases (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Eftihia Cocolakis collaborates with scholars based in Canada, United States and Italy. Eftihia Cocolakis's co-authors include Jean‐Jacques Lebrun, Suhad Ali, Wilson H. Miller, Katherine L. B. Borden, Caroline Rousseau, Brian Leber, Abdellatif Amri, Serge Lemay, Sarit Assouline and Stephen Caplan and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Eftihia Cocolakis

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eftihia Cocolakis Canada	12	898	342	123	120	83	20	1.2k
Nicholas Davies United Kingdom	15	584 0.7×	298 0.9×	86 0.7×	117 1.0×	55 0.7×	25	1000
Wenwen Chien United States	20	822 0.9×	250 0.7×	104 0.8×	212 1.8×	70 0.8×	29	1.1k
Zhijie Xiao China	18	569 0.6×	315 0.9×	136 1.1×	125 1.0×	131 1.6×	37	992
Haiyun Cheng United States	9	568 0.6×	472 1.4×	123 1.0×	193 1.6×	42 0.5×	12	944
Marco Cirò Italy	10	859 1.0×	320 0.9×	83 0.7×	225 1.9×	61 0.7×	11	1.1k
Shashirekha Shetty United States	10	584 0.7×	214 0.6×	98 0.8×	269 2.2×	92 1.1×	31	856
Susan Bakke United States	11	816 0.9×	711 2.1×	123 1.0×	121 1.0×	33 0.4×	12	1.4k
Andrea Ghelli Luserna di Rorà Italy	13	513 0.6×	303 0.9×	76 0.6×	98 0.8×	29 0.3×	38	735
Susumu Rokudai Japan	16	742 0.8×	386 1.1×	166 1.3×	177 1.5×	36 0.4×	29	1.0k
Suhu Liu United States	18	946 1.1×	476 1.4×	287 2.3×	333 2.8×	54 0.7×	34	1.4k

Countries citing papers authored by Eftihia Cocolakis

Since Specialization

Citations

This map shows the geographic impact of Eftihia Cocolakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eftihia Cocolakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eftihia Cocolakis more than expected).

Fields of papers citing papers by Eftihia Cocolakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eftihia Cocolakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eftihia Cocolakis. The network helps show where Eftihia Cocolakis may publish in the future.

Co-authorship network of co-authors of Eftihia Cocolakis

This figure shows the co-authorship network connecting the top 25 collaborators of Eftihia Cocolakis. A scholar is included among the top collaborators of Eftihia Cocolakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eftihia Cocolakis. Eftihia Cocolakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Assouline, Sarit, Julie Bergeron, Caroline Lambert, et al.. (2023). Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine. Haematologica. 108(11). 2946–2958. 6 indexed citations

Miller, Wilson H., Rahima Jamal, Eftihia Cocolakis, et al.. (2018). Systemic immune signature of inflammation in metastatic melanoma (MM) patients treated with ipilimumab (IPI) and carboplatin/paclitaxel (CP).. Journal of Clinical Oncology. 36(5_suppl). 185–185. 1 indexed citations

Jamal, Rahima, Réjean Lapointe, Eftihia Cocolakis, et al.. (2017). Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma. Journal for ImmunoTherapy of Cancer. 5(1). 83–83. 38 indexed citations

Jamal, Rahima, Léon C.L.T. van Kempen, Paméla Thébault, et al.. (2015). One-year overall survival (OS) and biomarker correlates from a phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM).. Journal of Clinical Oncology. 33(15_suppl). 9062–9062. 1 indexed citations

Zahreddine, Hiba Ahmad, Biljana Culjkovic‐Kraljacic, Sarit Assouline, et al.. (2014). The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation. Nature. 511(7507). 90–93. 149 indexed citations

Jamal, Rahima, Karl Bélanger, Jennifer Friedmann, et al.. (2014). A randomized phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM).. Journal of Clinical Oncology. 32(15_suppl). 9066–9066. 7 indexed citations

Nielsen, Torsten Holm, Nathalie A. Johnson, Lu Yao, et al.. (2013). Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient. Frontiers in Pharmacology. 4. 9–9. 6 indexed citations

Assouline, Sarit, Eftihia Cocolakis, & Katherine L.B. Borden. (2012). The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML). Cancers. 4(4). 1161–1179. 10 indexed citations

Pettersson, Filippa, Christina Yau, Biljana Culjkovic‐Kraljacic, et al.. (2011). Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer. Clinical Cancer Research. 17(9). 2874–2884. 106 indexed citations

10.

Batist, Gerald, Jian Wu, Alan Spatz, et al.. (2011). Resistance to Cancer Treatment: The Role of Somatic Genetic Events and the Challenges for Targeted Therapies. Frontiers in Pharmacology. 2. 59–59. 20 indexed citations

11.

Assouline, Sarit, Eftihia Cocolakis, Abdellatif Amri, et al.. (2011). A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,. Blood. 118(21). 3606–3606. 3 indexed citations

12.

Haines, Eric, Parham Minoo, Manuela Campiglio, et al.. (2009). Tyrosine Phosphorylation of Grb2: Role in Prolactin/Epidermal Growth Factor Cross Talk in Mammary Epithelial Cell Growth and Differentiation. Molecular and Cellular Biology. 29(10). 2505–2520. 29 indexed citations

13.

Assouline, Sarit, Eftihia Cocolakis, Caroline Rousseau, et al.. (2009). Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.. Blood. 114(22). 2085–2085. 1 indexed citations

14.

Assouline, Sarit, Biljana Čuljković, Eftihia Cocolakis, et al.. (2009). Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood. 114(2). 257–260. 247 indexed citations

15.

Cocolakis, Eftihia, Meiou Dai, Joanne Ho, et al.. (2007). Smad Signaling Antagonizes STAT5-mediated Gene Transcription and Mammary Epithelial Cell Differentiation. Journal of Biological Chemistry. 283(3). 1293–1307. 50 indexed citations

16.

Delom, Frédéric, et al.. (2006). Calnexin-dependent regulation of tunicamycin-induced apoptosis in breast carcinoma MCF-7 cells. Cell Death and Differentiation. 14(3). 586–596. 60 indexed citations

17.

Chughtai, Naila, et al.. (2006). Defining the Role of Prolactin as an Invasion Suppressor Hormone in Breast Cancer Cells. Cancer Research. 66(3). 1824–1832. 96 indexed citations

18.

Ho, Joanne, Eftihia Cocolakis, Víctor Dumas, et al.. (2005). The G protein‐coupled receptor kinase‐2 is a TGFβ‐inducible antagonist of TGFβ signal transduction. The EMBO Journal. 24(18). 3247–3258. 76 indexed citations

19.

Valderrama-Carvajal, Héctor, Eftihia Cocolakis, Annie Lacerte, et al.. (2002). Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nature Cell Biology. 4(12). 963–969. 138 indexed citations

20.

Cocolakis, Eftihia, Serge Lemay, Suhad Ali, & Jean‐Jacques Lebrun. (2001). The p38 MAPK Pathway Is Required for Cell Growth Inhibition of Human Breast Cancer Cells in Response to Activin. Journal of Biological Chemistry. 276(21). 18430–18436. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact